VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.20−0.03 (-13.13%)
Close on Nov 16, 2026Market cap $2.73MP/E –Yield –
VolitionRx enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
VolitionRx's enterprise value was $5.33M on Nov 11, 2026, against $40.23M a year earlier. Over the last 5 years it ranged from $5.23M to $147.01M, with a median of $57.53M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.33M | -83.8% |
| 2025 | Dec 31, 2025 | $32.98M | -38.6% |
| 2024 | Dec 31, 2024 | $53.69M | +11.5% |
| 2023 | Dec 29, 2023 | $48.13M | -62.0% |
| 2022 | Dec 30, 2022 | $126.64M | -13.9% |
| 2021 | Dec 31, 2021 | $147.01M | -12.8% |
| 2020 | Dec 31, 2020 | $168.64M | -4.9% |
| 2019 | Dec 31, 2019 | $177.38M | +260.2% |
| 2018 | Dec 31, 2018 | $49.24M | -24.9% |
| 2017 | Dec 29, 2017 | $65.58M | -31.2% |
| 2016 | Dec 30, 2016 | $95.36M | +27.9% |
| 2015 | Dec 31, 2015 | $74.56M | +39.7% |
| 2014 | Dec 31, 2014 | $53.39M | +95.6% |
| 2013 | Dec 31, 2013 | $27.29M | +1.3% |
| 2012 | Dec 31, 2012 | $26.95M | +151.2% |
| 2011 | Dec 5, 2011 | $10.73M | – |
See a number that looks wrong?